Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,424
archived clinical trials in
Cognitive Studies

Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Status: Enrolling
Updated:  4/13/2015
Veteran's Administration of Greater Los Angeles
mi
from
Los Angeles, CA
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Status: Enrolling
Updated: 4/13/2015
Veteran's Administration of Greater Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Status: Enrolling
Updated:  4/13/2015
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Status: Enrolling
Updated: 4/13/2015
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Status: Enrolling
Updated:  4/13/2015
Maryland Psychiatric Research Center
mi
from
Catonsville, MD
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Status: Enrolling
Updated: 4/13/2015
Maryland Psychiatric Research Center
mi
from
Catonsville, MD
Click here to add this to my saved trials
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Status: Enrolling
Updated:  4/13/2015
Massachusetts General Hospital
mi
from
Boston, MA
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Status: Enrolling
Updated: 4/13/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Status: Enrolling
Updated:  4/13/2015
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Status: Enrolling
Updated: 4/13/2015
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Status: Enrolling
Updated:  4/13/2015
Duke University School of Medicine
mi
from
Durham, NC
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Status: Enrolling
Updated: 4/13/2015
Duke University School of Medicine
mi
from
Durham, NC
Click here to add this to my saved trials
MRI Technical Development and Applications in Kidney Disease
Status: Enrolling
Updated:  7/23/2015
Center for Magnetic Resonance Research
mi
from
Minneapolis, MN
MRI Technical Development and Applications in Kidney Disease
Status: Enrolling
Updated: 7/23/2015
Center for Magnetic Resonance Research
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Thinking, Walking Outcomes by Type of Exercise
Benefits of Two Types of Therapeutic Exercise on Gait and Cognition
Status: Enrolling
Updated:  7/28/2015
University of Pittsburgh, Department of Physical Therapy
mi
from
Pittsburgh, PA
Thinking, Walking Outcomes by Type of Exercise
Benefits of Two Types of Therapeutic Exercise on Gait and Cognition
Status: Enrolling
Updated: 7/28/2015
University of Pittsburgh, Department of Physical Therapy
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cognitive Control and Physical Exercise
Cognitive Control and Physical Exercise: A Multi-Modal Intervention
Status: Enrolling
Updated:  8/3/2015
Columbia University Medical Center
mi
from
New York, NY
Cognitive Control and Physical Exercise
Cognitive Control and Physical Exercise: A Multi-Modal Intervention
Status: Enrolling
Updated: 8/3/2015
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Preoperative Cognitive Screening of Elderly Surgical Patients
Preoperative Cognitive Screening of Elderly Surgical Patients
Status: Enrolling
Updated:  9/3/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Preoperative Cognitive Screening of Elderly Surgical Patients
Preoperative Cognitive Screening of Elderly Surgical Patients
Status: Enrolling
Updated: 9/3/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects
A Single-center, Double-blind, Placebo-controlled, Randomized, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SUVN-G3031 After Single Ascending Doses and Multiple Ascending Doses in Healthy Male Subjects
Status: Enrolling
Updated:  9/7/2015
Quintiles, Inc.
mi
from
Overland Park, KA
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects
A Single-center, Double-blind, Placebo-controlled, Randomized, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SUVN-G3031 After Single Ascending Doses and Multiple Ascending Doses in Healthy Male Subjects
Status: Enrolling
Updated: 9/7/2015
Quintiles, Inc.
mi
from
Overland Park, KA
Click here to add this to my saved trials
Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
Double-Blind, Placebo-Controlled, Randomized Trial of Adjunctive, Flexibly-Dosed Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment In Major Depressive Disorder (MDD) Partially Responsive to Selective Serotonin Reuptake Inhibitor (SSRI) or Selective Norepinephrine Reuptake Inhibitor (SNRI) Monotherapy
Status: Enrolling
Updated:  9/21/2015
McLean Hospital
mi
from
Belmont, MA
Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
Double-Blind, Placebo-Controlled, Randomized Trial of Adjunctive, Flexibly-Dosed Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment In Major Depressive Disorder (MDD) Partially Responsive to Selective Serotonin Reuptake Inhibitor (SSRI) or Selective Norepinephrine Reuptake Inhibitor (SNRI) Monotherapy
Status: Enrolling
Updated: 9/21/2015
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia
An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia With Option of Prism Adaptation Treatment (PAT) Protocol
Status: Enrolling
Updated:  9/21/2015
Adler Aphasia Center
mi
from
Maywood, NJ
An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia
An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia With Option of Prism Adaptation Treatment (PAT) Protocol
Status: Enrolling
Updated: 9/21/2015
Adler Aphasia Center
mi
from
Maywood, NJ
Click here to add this to my saved trials
Interviewing Children About Past Events: Evaluating the NICHD Interview Protocol
Evaluating the NICHD Interview Protocol in an Analog Study
Status: Enrolling
Updated:  9/26/2015
National Institute of Child Health and Human Development (NICHD)
mi
from
Bethesda, MD
Interviewing Children About Past Events: Evaluating the NICHD Interview Protocol
Evaluating the NICHD Interview Protocol in an Analog Study
Status: Enrolling
Updated: 9/26/2015
National Institute of Child Health and Human Development (NICHD)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)
Cerebral Lesions and Outcomes After Cardiac Surgery (CLOCS)
Status: Enrolling
Updated:  9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)
Cerebral Lesions and Outcomes After Cardiac Surgery (CLOCS)
Status: Enrolling
Updated: 9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Psychosocial Adjustment After Radiation Therapy in Patients With Cancer
Psychosocial Adjustment During the Post-Radiation Treatment Transition
Status: Enrolling
Updated:  9/29/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Psychosocial Adjustment After Radiation Therapy in Patients With Cancer
Psychosocial Adjustment During the Post-Radiation Treatment Transition
Status: Enrolling
Updated: 9/29/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
Uh-Luicc
mi
from
Mentor, OH
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
Uh-Luicc
mi
from
Mentor, OH
Click here to add this to my saved trials
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
UH-Green Road
mi
from
South Euclid, OH
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
UH-Green Road
mi
from
South Euclid, OH
Click here to add this to my saved trials
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
UH-Chagrin Highlands
mi
from
Orange Village, OH
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
UH-Chagrin Highlands
mi
from
Orange Village, OH
Click here to add this to my saved trials
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
UH-Westlake
mi
from
Westlake, OH
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
UH-Westlake
mi
from
Westlake, OH
Click here to add this to my saved trials
Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer
The Geriatric-Oncology Database: A Resource for Advancing Research in Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer
The Geriatric-Oncology Database: A Resource for Advancing Research in Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer
The Geriatric-Oncology Database: A Resource for Advancing Research in Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
UHHS Chagrin Highlands Medical Center
mi
from
Cleveland, OH
Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer
The Geriatric-Oncology Database: A Resource for Advancing Research in Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
UHHS Chagrin Highlands Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Physiology of Chemotherapy Induced Fatigue and Cognitive Dysfunction in Early Stage Breast Cancer
Status: Enrolling
Updated:  10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Physiology of Chemotherapy Induced Fatigue and Cognitive Dysfunction in Early Stage Breast Cancer
Status: Enrolling
Updated: 10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Physiology of Chemotherapy Induced Fatigue and Cognitive Dysfunction in Early Stage Breast Cancer
Status: Enrolling
Updated:  10/1/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Physiology of Chemotherapy Induced Fatigue and Cognitive Dysfunction in Early Stage Breast Cancer
Status: Enrolling
Updated: 10/1/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cognitive Training for Nicotine Dependence
Cognitive Training for Nicotine Dependence
Status: Enrolling
Updated:  10/2/2015
Center for Interdiscplinary Research on Nicotine Addiction, University of Pennsylvania
mi
from
Philadelphia, PA
Cognitive Training for Nicotine Dependence
Cognitive Training for Nicotine Dependence
Status: Enrolling
Updated: 10/2/2015
Center for Interdiscplinary Research on Nicotine Addiction, University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery
Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery
Status: Enrolling
Updated:  10/11/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery
Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery
Status: Enrolling
Updated: 10/11/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 24-Week, Phase 2 Study of Two Doses of EVP-6124 Hydrochloride or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently Receiving Memantine Medication With or Without Additional Acetylcholinesterase Inhibitor Co-Medication
Status: Enrolling
Updated:  10/13/2015
Clinical Research Facility
mi
from
Delray Beach, FL
Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 24-Week, Phase 2 Study of Two Doses of EVP-6124 Hydrochloride or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently Receiving Memantine Medication With or Without Additional Acetylcholinesterase Inhibitor Co-Medication
Status: Enrolling
Updated: 10/13/2015
Clinical Research Facility
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 24-Week, Phase 2 Study of Two Doses of EVP-6124 Hydrochloride or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently Receiving Memantine Medication With or Without Additional Acetylcholinesterase Inhibitor Co-Medication
Status: Enrolling
Updated:  10/13/2015
Clinical Research Facility
mi
from
Albuquerque, NM
Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 24-Week, Phase 2 Study of Two Doses of EVP-6124 Hydrochloride or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently Receiving Memantine Medication With or Without Additional Acetylcholinesterase Inhibitor Co-Medication
Status: Enrolling
Updated: 10/13/2015
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Efficacy Trial of the Kids in Transition to School (KITS) Program for Children With Developmental Disabilities and Behavioral Problems
A Randomized Efficacy Trial of the Kids in Transition to School (KITS) Program for Children With Developmental Disabilities and Behavioral Problems
Status: Enrolling
Updated:  10/13/2015
Oregon Social Learning Center
mi
from
Eugene, OR
Efficacy Trial of the Kids in Transition to School (KITS) Program for Children With Developmental Disabilities and Behavioral Problems
A Randomized Efficacy Trial of the Kids in Transition to School (KITS) Program for Children With Developmental Disabilities and Behavioral Problems
Status: Enrolling
Updated: 10/13/2015
Oregon Social Learning Center
mi
from
Eugene, OR
Click here to add this to my saved trials
The Effect of Anticholinergics on Cognitive Function in the Elderly
The Effect of Anticholinergics on Cognitive Function in the Elderly: a Randomized Controlled Trial
Status: Enrolling
Updated:  10/19/2015
Unc Chapel Hill Urogynecology A2 Clinic
mi
from
Chapel Hill, NC
The Effect of Anticholinergics on Cognitive Function in the Elderly
The Effect of Anticholinergics on Cognitive Function in the Elderly: a Randomized Controlled Trial
Status: Enrolling
Updated: 10/19/2015
Unc Chapel Hill Urogynecology A2 Clinic
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Inpatient Functional and Cognitive Assessment in Older Adults With Acute Myelogenous Leukemia
Status: Enrolling
Updated:  10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Inpatient Functional and Cognitive Assessment in Older Adults With Acute Myelogenous Leukemia
Status: Enrolling
Updated: 10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)
Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)
Status: Enrolling
Updated:  10/29/2015
Posit Science Corporation
mi
from
San Francisco, CA
Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)
Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)
Status: Enrolling
Updated: 10/29/2015
Posit Science Corporation
mi
from
San Francisco, CA
Click here to add this to my saved trials
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Status: Enrolling
Updated:  10/30/2015
University of California at Los Angeles
mi
from
Los Angeles, CA
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Status: Enrolling
Updated: 10/30/2015
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Status: Enrolling
Updated:  10/30/2015
Yale University
mi
from
New Haven, CT
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Status: Enrolling
Updated: 10/30/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Status: Enrolling
Updated:  10/30/2015
Massachusetts General Hospital
mi
from
Lexington, MA
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Status: Enrolling
Updated: 10/30/2015
Massachusetts General Hospital
mi
from
Lexington, MA
Click here to add this to my saved trials
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Status: Enrolling
Updated:  10/30/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Status: Enrolling
Updated: 10/30/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Status: Enrolling
Updated:  10/30/2015
Emory University
mi
from
Atlanta, GA
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Status: Enrolling
Updated: 10/30/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
An 18-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
Status: Enrolling
Updated:  11/2/2015
Jose Biller, M.D.
mi
from
Maywood, IL
The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
An 18-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
Status: Enrolling
Updated: 11/2/2015
Jose Biller, M.D.
mi
from
Maywood, IL
Click here to add this to my saved trials
The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
An 18-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
Status: Enrolling
Updated:  11/2/2015
New York University School of Medicine
mi
from
New York, NY
The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
An 18-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
Status: Enrolling
Updated: 11/2/2015
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
An 18-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
Status: Enrolling
Updated:  11/2/2015
mi
from
Woodville,
The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
An 18-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
Status: Enrolling
Updated: 11/2/2015
mi
from
Woodville,
Click here to add this to my saved trials
Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya
A Pilot Study of Plasticity-Based and Adaptive Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya
Status: Enrolling
Updated:  11/18/2015
Stony Brook University
mi
from
Stony Brook, NY
Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya
A Pilot Study of Plasticity-Based and Adaptive Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya
Status: Enrolling
Updated: 11/18/2015
Stony Brook University
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline
Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline
Status: Enrolling
Updated:  11/30/2015
University of Cincinnati
mi
from
Cincinnati, OH
Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline
Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline
Status: Enrolling
Updated: 11/30/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated:  12/2/2015
Memory Enhancement Center of America, Inc.
mi
from
Eatontown, NJ
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated: 12/2/2015
Memory Enhancement Center of America, Inc.
mi
from
Eatontown, NJ
Click here to add this to my saved trials
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated:  12/2/2015
Comprehensive NeuroScience, Inc.
mi
from
St. Petersburg, FL
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated: 12/2/2015
Comprehensive NeuroScience, Inc.
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated:  12/2/2015
Memory Center of New Jersey, Inc.
mi
from
Monroe Twp, NJ
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated: 12/2/2015
Memory Center of New Jersey, Inc.
mi
from
Monroe Twp, NJ
Click here to add this to my saved trials
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated:  12/2/2015
Memory Enhancement Center Of Nj, Inc.
mi
from
Toms River, NJ
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated: 12/2/2015
Memory Enhancement Center Of Nj, Inc.
mi
from
Toms River, NJ
Click here to add this to my saved trials
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated:  12/2/2015
Senior Adults Specialty Research
mi
from
Austin, TX
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated: 12/2/2015
Senior Adults Specialty Research
mi
from
Austin, TX
Click here to add this to my saved trials
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated:  12/2/2015
Clinica Santa Maria, Div Neurologia
mi
from
Castellanza,
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 and to Explore the Effects in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated: 12/2/2015
Clinica Santa Maria, Div Neurologia
mi
from
Castellanza,
Click here to add this to my saved trials
African American Alzheimer's Progression Markers - CSF and Neuro-Imaging
Status: Enrolling
Updated:  12/3/2015
Emory University
mi
from
Atlanta, GA
African American Alzheimer's Progression Markers - CSF and Neuro-Imaging
Status: Enrolling
Updated: 12/3/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials